For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

Also called NCT05068349

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05068349
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05068349. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05-07 (actual); primary completion 2025-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.
Condition
Stroke
Condition
Cerebral Infarction
Condition
Brain Infarction
Condition
Brain Ischemia
Condition
Nervous System Diseases
Condition
Central Nervous System Diseases
Condition
Vascular Diseases
Intervention (Drug)
Butylphthalide
Lead sponsor
Qianfoshan Hospital (class: other)

Record details

Record id
cardio:ct-nct05068349
Content hash
59b83b692368887e503cfd50b4ca917ebb2fe828cd473bf0816cd916298d528e